Search For "cdsco"
SEC to discuss Dr Reddy's application for emergency use of Sputnik V vacci
Updated : 5 years, 1 month ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) is going to meet on Wednesday afternoon to discuss Dr Reddy's Laboratories application seeking emergency use approval (EUA) for SputnikV, a Russian Vaccine.
Read More
Approval to Covaxin premature, could be dangerous: Tharoor
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial. He urged Union Health Minister Dr Harsh Vardhan to wait till full trials o
Read More
COVID-19: Expert committee recommends restricted emergency use of SII, Bha
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.
Read More
Cabinet approves MoU between India, UK on cooperation in field of medical
Updated : 5 years, 4 months ago IST
New Delhi [India], November 4 (ANI): The Union Cabinet, chaired by Prime Minister Narendra Modi has given its approval for signing a Memorandum of Understanding (MoU) between the Central Drugs Standard Control Organization (CDSCO), India, and the United Kingdom Medicines and Healthcare Pr
Read More
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biote
Updated : 5 years, 5 months ago IST
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Read More
Submit previous trial data for Covaxin before rolling out phase III: Drug
Updated : 5 years, 5 months ago IST
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Read More
Drugs control organisation issues guidelines for trial, marketing of vacci
Updated : 5 years, 6 months ago IST
New Delhi [India], September 18 (ANI): The Central Drugs Standard Control Organisation (CDSCO) said the requirements and guidelines to conduct clinical trial or grant of permission for the marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 201
Read More
COVID-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injec
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 7 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 8 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More
Top drug regulator suspends import license of 19 firms for their COVID-19
Updated : 5 years, 8 months ago IST
New Delhi [India], July 25 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import licenses of at least 19 firms for their respective COVID-19 test kits after USFDA removed the manufacturer from their list of the product of serology test kits for coronavirus.
Read More
Top drug regulator CDSCO suspends import license of Mumbai-based firm for
Updated : 5 years, 8 months ago IST
New Delhi [India], July 24 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
Read More